ETF Managers Group, LLC Meridian Bioscience Inc Transaction History

ETF Managers Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 23, 2023	SELL	$31.15 - $33.39 $61,770 - $66,212	-1,983 Reduced 15.36%	10,927 $362,000
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $26,481 - $28,752	-857 Reduced 6.23%	12,910 $407,000
Q2 2022 Aug 15, 2022	BUY	$23.75 - $31.69 $13,300 - $17,746	560 Added 4.24%	13,767 $434,000
Q1 2022 May 13, 2022	BUY	$19.97 - $26.94 $2,016 - $2,720	101 Added 0.77%	13,207 $348,000
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $47,561 - $58,865	-2,724 Reduced 17.21%	13,106 $264,000
Q3 2021 Nov 15, 2021	BUY	$17.35 - $22.5 $52,917 - $68,625	3,050 Added 23.87%	15,830 $308,000
Q2 2021 Aug 16, 2021	SELL	$18.01 - $28.32 $639,967 - $1.01 Million	-35,534 Reduced 73.55%	12,780 $288,000
Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $318,274 - $481,438	16,107 Added 50.01%	48,314 $1.24 Million
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $128,860 - $177,438	8,192 Added 34.11%	32,207 $626,000
Q3 2020 Nov 16, 2020	BUY	$13.54 - $26.41 $160,652 - $313,354	11,865 Added 97.65%	24,015 $414,000
Q2 2020 Aug 14, 2020	BUY	$7.84 - $23.29 $95,256 - $282,973	12,150 New	12,150 $265,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.